# Suppressive Functions of Veratramine on PM2.5-Induced Oxidative Stress

**Authors:** Gyuri Han, Ga Eun Kim, Dong Ho Park, Jong-Sup Bae

PMC · DOI: 10.3390/biom16020239 · Biomolecules · 2026-02-03

## TL;DR

Veratramine reduces lung damage caused by PM2.5 pollution by fighting oxidative stress and regulating cell pathways.

## Contribution

Veratramine's novel protective effects against PM2.5-induced oxidative injury and autophagy modulation are demonstrated.

## Key findings

- Veratramine enhances cell viability and reduces oxidative stress in PM2.5-exposed cells.
- Veratramine suppresses TLR4 and autophagy markers while promoting mTOR phosphorylation.
- Veratramine restores SGK1 expression, a key cell survival factor reduced by PM2.5.

## Abstract

Background: Particulate matter (PM2.5) inhalation induces pulmonary disorders through oxidative stress. Veratramine (VRT), a steroidal alkaloid derived from Veratrum species, exhibits protective pharmacological potential. Therefore, this study aims to investigate the protective effects of VRT against PM2.5-induced oxidative injury and the underlying molecular mechanisms. Methods: In vitro experiments were conducted using pulmonary artery endothelial cells (HPAECs), which were exposed to PM2.5 (25–100 μg/mL) ± VRT (2–50 μM) or Dexamethasone (DEX; 50 μM) for 24–48 h. Measurements included 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide viability, Lactate dehydrogenase ELISA, 2′,7′-dichlorodihydrofluorescein diacetate reactive oxygen species (ROS), superoxide dismutase/catalase kits, and Western blots (Bax, serum, and glucocorticoid-regulated kinase 1 (SGK1), microtubule-associated protein 1 light chain 3 (LC3), Toll-like receptor (TLR4), and mechanistic target of rapamycin (mTOR)). Results: PM2.5 exposure reduced HPAEC viability in a dose- and time-dependent manner, likely due to increased lactate dehydrogenase leakage and intracellular ROS accumulation. Oxidative stress correlated with altered superoxide dismutase and catalase activities, with suppression of SGK1, a key factor in cell survival. VRT treatment enhanced cell viability, mitigated oxidative stress, and restored SGK1 expression. Moreover, VRT promoted mTOR phosphorylation and markedly suppressed PM2.5-induced increases in TLR4, MyD88, and the autophagy markers LC3 II and Beclin 1. Conclusions: Collectively, these findings indicate that VRT protects against PM2.5-induced pulmonary injury by modulating oxidative stress and the mTOR-associated autophagy pathway, highlighting its potential as a therapeutic candidate for PM2.5-related respiratory disorders.

## Linked entities

- **Genes:** BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581], SGK1 (serum/glucocorticoid regulated kinase 1) [NCBI Gene 6446], MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557], TLR4 (toll like receptor 4) [NCBI Gene 7099], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475], MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615], BECN1 (beclin 1) [NCBI Gene 8678]
- **Chemicals:** Veratramine (PubChem CID 6070), Dexamethasone (PubChem CID 5743)

## Full-text entities

- **Genes:** PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412] {aka CD106, INCAM-100}, CAT (catalase) [NCBI Gene 847], NUP62 (nucleoporin 62) [NCBI Gene 23636] {aka IBSN, SNDI, p62}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, PRKDC (protein kinase, DNA-activated, catalytic subunit) [NCBI Gene 5591] {aka DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, SGK1 (serum/glucocorticoid regulated kinase 1) [NCBI Gene 6446] {aka SGK}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, BECN1 (beclin 1) [NCBI Gene 8678] {aka ATG6, VPS30, beclin1}, MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290] {aka CCM4, CLAPO, CLOVE, CWS5, HMH, MCAP}, ATG5 (autophagy related 5) [NCBI Gene 9474] {aka APG5, APG5-LIKE, APG5L, ASP, SCAR25, hAPG5}, GSTK1 (glutathione S-transferase kappa 1) [NCBI Gene 373156] {aka GST, GST 13-13, GST13, GST13-13, GSTK1-1, hGSTK1}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, ATG12 (autophagy related 12) [NCBI Gene 9140] {aka APG12, APG12L, FBR93, HAPG12}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, ULK1 (unc-51 like autophagy activating kinase 1) [NCBI Gene 8408] {aka ATG1, ATG1A, UNC51, Unc51.1, hATG1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, TXNIP (thioredoxin interacting protein) [NCBI Gene 10628] {aka ARRDC6, EST01027, HHCPA78, THIF, VDUP1}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, NR3C1 (nuclear receptor subfamily 3 group C member 1) [NCBI Gene 2908] {aka GCCR, GCR, GCRST, GR, GRL}, MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}
- **Diseases:** mycoplasma (MESH:D009175), cardiovascular toxicity (MESH:D002318), cytotoxicity (MESH:D064420), endothelial injury (MESH:D057772), inflammatory cytokines (MESH:D000080424), sepsis (MESH:D018805), inflammation (MESH:D007249), injury to (MESH:D014947), mitochondrial dysfunction (MESH:D028361), acute coronary syndrome (MESH:D054058), lung cancer (MESH:D008175), endothelial dysfunction (MESH:D014652), pulmonary disorders (MESH:D008171), lung and vascular injury (MESH:D055370), asthma (MESH:D001249), respiratory disorders (MESH:D012131), COPD (MESH:D029424), pulmonary inflammation (MESH:D011014), stroke (MESH:D020521), pulmonary dysfunction (MESH:D011660), hypotension (MESH:D007022), bradycardia (MESH:D001919)
- **Chemicals:** H2O2 (MESH:D006861), superoxide anions (MESH:D013481), EGM-2 (-), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MESH:C022616), sodium (MESH:D012964), DEX (MESH:D003907), MTT (MESH:C070243), polyphenols (MESH:D059808), LY294002 (MESH:C085911), GSH (MESH:D005978), lipid (MESH:D008055), GDC-0941 (MESH:C532162), 2-methoxyestradiol (MESH:D000077584), VRT (MESH:C009649), PBS (MESH:D007854), KCl (MESH:D011189), N-acetylcysteine (MESH:D000111), polyvinylidene fluoride (MESH:C024865), flavonoids (MESH:D005419), chloroquine (MESH:D002738), ROS (MESH:D017382), metal (MESH:D008670), sodium deoxycholate (MESH:D003840), NaCl (MESH:D012965), trypan blue (MESH:D014343), nitrates (MESH:D009566), formazan (MESH:D005562), sulfates (MESH:D013431), oxygen (MESH:D010100), Ni (MESH:D009532), NP-40 (MESH:C010615), MDA (MESH:D015104), sulforaphane (MESH:C016766), 2',7'-dichlorodihydrofluorescein diacetate (MESH:C110400), rapamycin (MESH:D020123), water (MESH:D014867), tetrazolium salt (MESH:D013778), Fe (MESH:D007501), DCFH-DA (MESH:C029569), Dex (MESH:D003915), vitamin C (MESH:D001205), bafilomycin A1 (MESH:C040929), SDS (MESH:D012967), alkaloid (MESH:D000470), Cu (MESH:D003300), 8-OHdG (MESH:D000080242), PAHs (MESH:D011084), hydroxyl radicals (MESH:D017665)
- **Species:** Veratrum (genus) [taxon 50241], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006), artery — Homo sapiens (Human), Finite cell line (CVCL_A2CZ), HPAECs — Homo sapiens (Human), Finite cell line (CVCL_3716), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), BEAS-2B — Homo sapiens (Human), Transformed cell line (CVCL_0168)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938814/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938814/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938814/full.md

---
Source: https://tomesphere.com/paper/PMC12938814